Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of bilastine 20 mg under fasting conditions in healthy Thai volunteers
TCTR20190824002Completed
- Sponsor
- All Research
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bilastine (2 arms), sponsored by All Research. Primary endpoints: Cmax, AUC0-t and 1 more. Started Oct 2019; status: completed.
02
Drugs
bilastine
Beyond the preview
Go deeper on TCTR20190824002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190824002.